Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   Drugging multiple same-allele driver mutations in cancer
  2. Nussinov,Ruth; Zhang,Mingzhen; Maloney,Ryan; Jang, Hyunbum
  3. Expert Opinion on Drug Discovery. 2021, Aug; 16(8): 823-828.
  1. 2.   NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling
  2. Pinto, Inês; Duque, Mafalda; Gonçalves, Joana; Akkapeddi, Padma; Oliveira, Mariana L; Cabrita, Rita; Yunes, J Andrés; Durum,Scott; Barata, João T; Fragoso, Rita
  3. ONCOGENE. 2020, JAN; 39(5): 975-986.
  1. 3.   Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models
  2. Taylor, J. G.; Cheuk, A. T.; Tsang, P. S.; Chung, J. Y.; Song, Y. K.; Desai, K.; Yu, Y. L.; Chen, Q. R.; Shah, K.; Youngblood, V.; Fang, J.; Kim, S. Y.; Yeung, C.; Helman, L. J.; Mendoza, A.; Ngo, V.; Staudt, L. M.; Wei, J. S.; Khanna, C.
  3. Journal of Clinical Investigation. 2009 119(11): 3395-3407.
  1. 4.   The role of IL-6 and STAT3 in inflammation and cancer
  2. Hodge, D. R.; Hurt, E. M.; Farrar, W. L.
  3. European Journal of Cancer. 2005, NOV; 41(16): 2502-2512.
  1. 5.   Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: A clinical and molecular genetic investigation
  2. Matyakhina, L.; Freedman, R. J.; Bourdeau, I.; Wei, M. H.; Stergiopoulos, S. G.; Chidakel, A.; Walther, M.; bu-Asab, M.; Tsokos, M.; Keil, M.; Toro, J.; Linehan, W. M.; Stratakis, C. A.
  3. Journal of Clinical Endocrinology & Metabolism. 2005, JUN; 90(6): 3773-3779.
  1. 6.   PKC delta plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant
  2. Jelacic, T.; Linnekin, D.
  3. Blood. 2005, MAR 1; 105(5): 1923-1929.
  1. 7.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
  1. 8.   Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells
  2. Hodge, D. R.; Xiao, W. H.; Wang, L. H.; Li, D. P.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2004 3(2): 188-194.
  1. 9.   Phosphatidylinositol 3 '-kinase is required for growth of mast cells expressing the Kit catalytic domain mutant
  2. Shivakrupa, R.; Bernstein, A.; Watring, N.; Linnekin, D.
  3. Cancer Research. 2003 63(15): 4412-4419.
  1. 10.   Cross-talk between RON receptor tyrosine kinase and other transmembrane receptors
  2. Danilkovitch-Miagkova, A.; Leonard, E. J.
  3. Histology and Histopathology. 2001 16(2): 623-631.
  1. 11.   Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src
  2. Nakaigawa, N.; Weirich, G.; Schmidt, L.; Zbar, B.
  3. Oncogene. 2000 19(26): 2996-3002.
  1. 12.   Novel mutations of the MET proto-oncogene in papillary renal carcinomas
  2. Schmidt, L.; Junker, K.; Nakaigawa, N.; Kinjerski, T.; Weirich, G.; Miller, M.; Lubensky, I.; Neumann, H. P. H.; Brauch, H.; Decker, J.; Vocke, C.; Brown, J. A.; Jenkins, R.; Richard, S.; Bergerheim, U.; Gerrard, B.; Dean, M.; Linehan, W. M.; Zbar, B.
  3. Oncogene. 1999 18(14): 2343-2350.
  1. 13.   Skin Tumorigenesis and Ki-Ras and Ha-Ras Mutations in Tumors From Adult Mice Exposed in Utero to 3'-Azido-2',3'-Dideoxythymidine
  2. Zhang, Z. H.; Diwan, B. A.; Anderson, L. M.; Logsdon, D.; Olivero, O. A.; Haines, D. C.; Rice, J. M.; Yuspa, S. H.; Poirier, M. C.
  3. Molecular Carcinogenesis. 1998 23(1): 45-51.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel